Johnson & Johnson to Evercare
Colella began his executive career at Johnson & Johnson in commercial strategy, business development, and operations roles, then served as a president at Smith & Nephew, leading businesses in EMEA, emerging markets, Asia Pacific, Canada, and Latin America.1
He was group chief executive of Evercare Group, a TPG portfolio company, overseeing 30 hospitals, 16 clinics, and over 100 diagnostic centers. He has lived and worked in Italy, the Czech Republic, the UAE, Singapore, Switzerland, and the UK.2,1
Leading CMR
He joined CMR as chief commercial officer in 2023, became interim CEO in October 2024, and was named CEO and a board member in January 2025.2
In October 2026 he agreed a strategic alliance under which Stryker will invest about $400 million in CMR, act as exclusive US sales agent for Versius, and hold an option to acquire the company. He is also chairman of Beyeonics Surgical.3,1
Links
Sources
Photo: CMR Surgical, Management team.
